BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26471359)

  • 21. p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.
    Tweddle DA; Malcolm AJ; Cole M; Pearson AD; Lunec J
    Am J Pathol; 2001 Jun; 158(6):2067-77. PubMed ID: 11395384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
    Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
    Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct recruitment of N-myc to target gene promoters.
    Mac SM; D'Cunha CA; Farnham PJ
    Mol Carcinog; 2000 Oct; 29(2):76-86. PubMed ID: 11074604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
    Corvi R; Savelyeva L; Breit S; Wenzel A; Handgretinger R; Barak J; Oren M; Amler L; Schwab M
    Oncogene; 1995 Mar; 10(6):1081-6. PubMed ID: 7700632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output.
    Chen L; Li Z; Zwolinska AK; Smith MA; Cross B; Koomen J; Yuan ZM; Jenuwein T; Marine JC; Wright KL; Chen J
    EMBO J; 2010 Aug; 29(15):2538-52. PubMed ID: 20588255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification.
    Ullius A; Lüscher-Firzlaff J; Costa IG; Walsemann G; Forst AH; Gusmao EG; Kapelle K; Kleine H; Kremmer E; Vervoorts J; Lüscher B
    Nucleic Acids Res; 2014 Jun; 42(11):6901-20. PubMed ID: 24782528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.
    Chen X; Xie W; Gu P; Cai Q; Wang B; Xie Y; Dong W; He W; Zhong G; Lin T; Huang J
    Sci Rep; 2015 Feb; 5():8293. PubMed ID: 25656485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
    Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
    Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
    Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitotic gene regulation by the N-MYC-WDR5-PDPK1 nexus.
    Streeter SA; Williams AG; Evans JR; Wang J; Guarnaccia AD; Florian AC; Al-Tobasei R; Liu Q; Tansey WP; Weissmiller AM
    BMC Genomics; 2024 Apr; 25(1):360. PubMed ID: 38605297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
    Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A
    Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-damaging drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
    Li T; Wang L; Ke XX; Gong XY; Wan JH; Hao XW; Xu M; Xiang Z; Cui ZB; Cui H
    Cell Biol Int; 2012 Apr; 36(4):331-7. PubMed ID: 21929510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.
    Cotterman R; Knoepfler PS
    PLoS One; 2009 Jun; 4(6):e5799. PubMed ID: 19495417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1.
    Tee AE; Ling D; Nelson C; Atmadibrata B; Dinger ME; Xu N; Mizukami T; Liu PY; Liu B; Cheung B; Pasquier E; Haber M; Norris MD; Suzuki T; Marshall GM; Liu T
    Oncotarget; 2014 Apr; 5(7):1793-804. PubMed ID: 24742640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.
    Guccione E; Bassi C; Casadio F; Martinato F; Cesaroni M; Schuchlautz H; Lüscher B; Amati B
    Nature; 2007 Oct; 449(7164):933-7. PubMed ID: 17898714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1.
    Shahbazi J; Scarlett CJ; Norris MD; Liu B; Haber M; Tee AE; Carrier A; Biankin AV; London WB; Marshall GM; Lock RB; Liu T
    Oncotarget; 2014 Jun; 5(12):4257-68. PubMed ID: 24952595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
    Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
    Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
    Carugo A; Genovese G; Seth S; Nezi L; Rose JL; Bossi D; Cicalese A; Shah PK; Viale A; Pettazzoni PF; Akdemir KC; Bristow CA; Robinson FS; Tepper J; Sanchez N; Gupta S; Estecio MR; Giuliani V; Dellino GI; Riva L; Yao W; Di Francesco ME; Green T; D'Alesio C; Corti D; Kang Y; Jones P; Wang H; Fleming JB; Maitra A; Pelicci PG; Chin L; DePinho RA; Lanfrancone L; Heffernan TP; Draetta GF
    Cell Rep; 2016 Jun; 16(1):133-147. PubMed ID: 27320920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.